HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Accuracy of gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.

AbstractOBJECTIVE:
To prospectively assess the accuracy of gadofosveset-enhanced magnetic resonance imaging (MRI) for nodal staging and restaging in rectal cancer.
BACKGROUND:
Accurate preoperative assessment of nodal disease in rectal cancer impacts treatment management. Staging with modern imaging techniques (computed tomography, MRI and endorectal ultrasound) is insufficiently accurate for clinical decision making. This study aims to assess the accuracy of MRI using a novel lymph node magnetic resonance contrast, gadofosveset, for nodal staging and restaging in rectal cancer using a per node comparison with histology as the reference standard.
METHODS:
Sixty-eight patients underwent gadofosveset-enhanced MRI at 1.5T. Twenty-six patients (primary staging group I) were treated with total mesorectal excision (with or without preoperative 5 × 5 Gy) and 42 (restaging group II) underwent a long course of chemoradiation followed by a restaging MRI and resection. Nodes were scored as benign or malignant by 2 radiologists (experienced and junior reader) first on standard MRI, then on gadofosveset-enhanced MRI. For group I the primary staging MRI was compared with histology. In group II the second, restaging MRI was compared with histology.
RESULTS:
For the experienced reader, sensitivity, specificity, and area under the ROC-curve (AUC) improved from 76%, 82% and 0.84 on standard MRI to 80%, 97% and 0.96 on gadofosveset-MRI (P < 0.001). For the junior reader results improved from 69%, 85%, and 0.85 on standard MRI to 70%, 95%, and 0.93 on gadofosveset-MRI (P = 0.03). Interobserver agreement was good on both standard MRI (κ 0.73) and gadofosveset-MRI (κ 0.71).
CONCLUSIONS:
This study shows high reproducibility and significantly improved accuracy compared to standard MRI for gadofosveset-enhanced MRI for nodal staging and restaging in rectal cancer.
AuthorsDoenja M J Lambregts, Geerard L Beets, Monique Maas, Alfons G H Kessels, Frans C H Bakers, Vincent C Cappendijk, Sanne M E Engelen, Max J Lahaye, Adriaan P de Bruïne, Guido Lammering, Tim Leiner, Jan L Verwoerd, Joachim E Wildberger, Regina G H Beets-Tan
JournalAnnals of surgery (Ann Surg) Vol. 253 Issue 3 Pg. 539-45 (Mar 2011) ISSN: 1528-1140 [Electronic] United States
PMID21239980 (Publication Type: Journal Article)
Chemical References
  • Contrast Media
  • Organometallic Compounds
  • Gadolinium
  • gadofosveset trisodium
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Contrast Media
  • Female
  • Gadolinium
  • Humans
  • Image Enhancement
  • Image Processing, Computer-Assisted
  • Lymph Node Excision
  • Lymph Nodes (pathology)
  • Lymphatic Metastasis (pathology)
  • Magnetic Resonance Imaging (methods)
  • Male
  • Middle Aged
  • Minimally Invasive Surgical Procedures
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Organometallic Compounds
  • Prognosis
  • Prospective Studies
  • Radiotherapy, Adjuvant
  • Rectal Neoplasms (drug therapy, pathology, radiotherapy, surgery)
  • Rectum (pathology, surgery)
  • Sensitivity and Specificity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: